These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 7477801

  • 1. Combined cognitive-behavioral, psychopharmacological and nutritional therapy in eating disorders. 2. Anorexia nervosa--binge-eating/purging type.
    Brambilla F, Draisci A, Peirone A, Brunetta M.
    Neuropsychobiology; 1995; 32(2):64-7. PubMed ID: 7477801
    [Abstract] [Full Text] [Related]

  • 2. Combined cognitive-behavioral, psychopharmacological and nutritional therapy in eating disorders. 1. Anorexia nervosa--restricted type.
    Brambilla F, Draisci A, Peirone A, Brunetta M.
    Neuropsychobiology; 1995; 32(2):59-63. PubMed ID: 7477800
    [Abstract] [Full Text] [Related]

  • 3. Combined cognitive-behavioral, psychopharmacological and nutritional therapy in bulimia nervosa.
    Brambilla F, Draisci A, Peirone A, Brunetta M.
    Neuropsychobiology; 1995; 32(2):68-71. PubMed ID: 7477802
    [Abstract] [Full Text] [Related]

  • 4. An open trial of fluoxetine for adolescents with bulimia nervosa.
    Kotler LA, Devlin MJ, Davies M, Walsh BT.
    J Child Adolesc Psychopharmacol; 2003; 13(3):329-35. PubMed ID: 14642021
    [Abstract] [Full Text] [Related]

  • 5. The efficacy and acceptability of amineptine versus fluoxetine in major depression.
    Dalery J, Rochat C, Peyron E, Bernard G.
    Int Clin Psychopharmacol; 1997 Jul; 12 Suppl 3():S35-8. PubMed ID: 9347391
    [Abstract] [Full Text] [Related]

  • 6. Medication and psychotherapy in the treatment of bulimia nervosa.
    Walsh BT, Wilson GT, Loeb KL, Devlin MJ, Pike KM, Roose SP, Fleiss J, Waternaux C.
    Am J Psychiatry; 1997 Apr; 154(4):523-31. PubMed ID: 9090340
    [Abstract] [Full Text] [Related]

  • 7. Short-term course of depressive symptoms in patients with eating disorders.
    Wamboldt FS, Kaslow NJ, Swift WJ, Ritholz M.
    Am J Psychiatry; 1987 Mar; 144(3):362-4. PubMed ID: 3469919
    [Abstract] [Full Text] [Related]

  • 8. Psychosocial and pharmacological treatment of eating disorders: a review of research findings.
    Peterson CB, Mitchell JE.
    J Clin Psychol; 1999 Jun; 55(6):685-97. PubMed ID: 10445860
    [Abstract] [Full Text] [Related]

  • 9. Comparing cognitive behavioural therapy for eating disorders integrated with behavioural weight loss therapy to cognitive behavioural therapy-enhanced alone in overweight or obese people with bulimia nervosa or binge eating disorder: study protocol for a randomised controlled trial.
    Palavras MA, Hay P, Touyz S, Sainsbury A, da Luz F, Swinbourne J, Estella NM, Claudino A.
    Trials; 2015 Dec 18; 16():578. PubMed ID: 26683478
    [Abstract] [Full Text] [Related]

  • 10. Fluoxetine and fluvoxamine combined with individual cognitive-behaviour therapy in binge eating disorder: a one-year follow-up study.
    Ricca V, Mannucci E, Mezzani B, Moretti S, Di Bernardo M, Bertelli M, Rotella CM, Faravelli C.
    Psychother Psychosom; 2001 Dec 18; 70(6):298-306. PubMed ID: 11598429
    [Abstract] [Full Text] [Related]

  • 11. Objective and subjective binge eating in underweight eating disorders: associated features and treatment outcome.
    Dalle Grave R, Calugi S, Marchesini G.
    Int J Eat Disord; 2012 Apr 18; 45(3):370-6. PubMed ID: 21656542
    [Abstract] [Full Text] [Related]

  • 12. Management of eating disorders.
    Berkman ND, Bulik CM, Brownley KA, Lohr KN, Sedway JA, Rooks A, Gartlehner G.
    Evid Rep Technol Assess (Full Rep); 2006 Apr 18; (135):1-166. PubMed ID: 17628126
    [Abstract] [Full Text] [Related]

  • 13. Ghrelin concentrations and cardiac vagal tone are decreased after pharmacologic and cognitive-behavioral treatment in patients with bulimia nervosa.
    Tanaka M, Nakahara T, Muranaga T, Kojima S, Yasuhara D, Ueno H, Nakazato M, Inui A.
    Horm Behav; 2006 Aug 18; 50(2):261-5. PubMed ID: 16643914
    [Abstract] [Full Text] [Related]

  • 14. Cognitive behavioral therapy and fluoxetine as adjuncts to group behavioral therapy for binge eating disorder.
    Devlin MJ, Goldfein JA, Petkova E, Jiang H, Raizman PS, Wolk S, Mayer L, Carino J, Bellace D, Kamenetz C, Dobrow I, Walsh BT.
    Obes Res; 2005 Jun 18; 13(6):1077-88. PubMed ID: 15976151
    [Abstract] [Full Text] [Related]

  • 15. The use of citalopram in an integrated approach to the treatment of eating disorders: an open study.
    Calandra C, Gulino V, Inserra L, Giuffrida A.
    Eat Weight Disord; 1999 Dec 18; 4(4):207-10. PubMed ID: 10728184
    [Abstract] [Full Text] [Related]

  • 16. Fluoxetine dependence in a former amineptine abuser.
    Taïeb O, Larroche C, Dutray B, Baubet T, Moro MR.
    Am J Addict; 2004 Dec 18; 13(5):498-500. PubMed ID: 15764428
    [No Abstract] [Full Text] [Related]

  • 17. Postremission predictors of relapse in women with eating disorders.
    Keel PK, Dorer DJ, Franko DL, Jackson SC, Herzog DB.
    Am J Psychiatry; 2005 Dec 18; 162(12):2263-8. PubMed ID: 16330589
    [Abstract] [Full Text] [Related]

  • 18. Out of control! the most effective way to help the binge-eating patient.
    McGown A, Whitbread J.
    J Psychosoc Nurs Ment Health Serv; 1996 Jan 18; 34(1):30-7. PubMed ID: 8720013
    [Abstract] [Full Text] [Related]

  • 19. Cognitive behavioral therapy and fluoxetine for binge eating disorder: two-year follow-up.
    Devlin MJ, Goldfein JA, Petkova E, Liu L, Walsh BT.
    Obesity (Silver Spring); 2007 Jul 18; 15(7):1702-9. PubMed ID: 17636088
    [Abstract] [Full Text] [Related]

  • 20. Effectiveness of fluoxetine therapy in bulimia nervosa regardless of comorbid depression.
    Goldstein DJ, Wilson MG, Ascroft RC, al-Banna M.
    Int J Eat Disord; 1999 Jan 18; 25(1):19-27. PubMed ID: 9924649
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.